Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ...

8 October 2025 A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their ...

Just weeks into his tenure, USPTO director John Squires is blitzing US patent policy by taking control of how and when patent challenges can be brought, with proposed rules that could sharply limit ...

Hire brings trade secrets and AI litigation expertise from Cooley as firm adds 14th US litigation partner this year. If you ...

Isomorphic Labs' head of IP shares why the first wave of AI-driven drug development stumbled, how data became pharma's most ...

Speakers include Raymond Doss, associate general counsel for IP and litigation at Amgen, Reena Bajpai, senior counsel at ...

The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent ...

Panellists discuss data, AI and patents in a session at the CIPA Annual Congress 2025. L-R: Greg Corcoran, Rose Hughes, Ben ...

27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic ...

A recent survey shows heavy opposition to the proposal which could leave university licensing struggling, chill investment in ...

8 May 2025 Industry body says agreement doesn’t address ‘longstanding industry concerns’ about IP | Deal criticised for ‘lack ...